Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression
Authors:
- 1 November 2011
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 128 (5) , 452-457
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Lumican inhibits cell migration through α2β1 integrinExperimental Cell Research, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- DNAzymes to mouse β1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growthCancer Gene Therapy, 2009
- Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanomaClinical and Experimental Dermatology, 2007
- Lumican, a small leucine‐rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytesIUBMB Life, 2006
- Reciprocal interactions between adhesion receptor signaling and MMP regulationCancer and Metastasis Reviews, 2006
- Pancreatic tumor cells influence the composition of the extracellular matrixBiochemical and Biophysical Research Communications, 2004
- A Syndrome of Joint Laxity and Impaired Tendon Integrity in Lumican- and Fibromodulin-deficient MiceJournal of Biological Chemistry, 2002
- Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cellsThe Journal of Pathology, 2001
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970